A detailed history of Russell Investments Group, Ltd. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 744,687 shares of TERN stock, worth $4.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
744,687
Previous 648,116 14.9%
Holding current value
$4.32 Million
Previous $4.41 Million 40.72%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.49 - $10.8 $626,745 - $1.04 Million
96,571 Added 14.9%
744,687 $6.21 Million
Q2 2024

Aug 08, 2024

BUY
$4.54 - $8.2 $68,785 - $124,238
15,151 Added 2.39%
648,116 $4.41 Million
Q1 2024

May 08, 2024

BUY
$4.86 - $8.19 $1.73 Million - $2.91 Million
355,224 Added 127.9%
632,965 $4.15 Million
Q4 2023

Feb 05, 2024

BUY
$3.37 - $6.86 $935,987 - $1.91 Million
277,741 New
277,741 $1.8 Million

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $218M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.